Retinal vascular calibre as a predictor of incidence and progression of diabetic retinopathy

Clinical and Experimental Optometry

Volumn 95, Issue 3, 2012, Pages 290-296

  Ding, Jie ^a,b,c   Ikram, M Kamran ^a,b,d   Cheung, Carol Y ^a,b,c   Wong, Tien Yin ^a,b,c,e  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Diabetes; Diabetic retinopathy; Retina; Retinal vascular calibre

Indexed keywords

DIABETIC RETINOPATHY; DISEASE COURSE; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LONGITUDINAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; RETINA BLOOD VESSEL; REVIEW; RISK FACTOR;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; RETINAL VESSELS; RISK FACTORS;

EID: 84861225870     PISSN: 08164622     EISSN: 14440938     Source Type: Journal    
DOI: 10.1111/j.1444-0938.2012.00725.x     Document Type: Review

References (42)

1. Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy: a systematic review. JAMA 2007; 298: 902-916.
2. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet 2010; 376: 124-136.
3. Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, Forder P etal. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005; 366: 1849-1861.
4. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M etal. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572.
5. Mitchell P, Wong TY. DIRECT new treatments for diabetic retinopathy. Lancet 2008; 372: 1361-1363.
6. Sasongko MB, Wong TY, Nguyen TT, Kawasaki R, Jenkins A, Shaw J, Wang JJ. Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids. Diabetes Care 2011; 34: 474-479.
7. Nguyen TT, Alibrahim E, Islam FM, Klein R, Klein BE, Cotch MF, Shea S etal. Inflammatory, hemostatic and other novel biomarkers for diabetic retinopathy: the multi-ethnic study of atherosclerosis. Diabetes Care 2009; 32: 1704-1709.
8. Savage HI, Hendrix JW, Peterson DC, Young H, Wilkinson CP. Differences in pulsatile ocular blood flow among three classifications of diabetic retinopathy. Invest Ophthalmol Vis Sci 2004; 45: 4504-4509.
9. Luu CD, Szental JA, Lee SY, Lavanya R, Wong TY. Correlation between retinal oscillatory potentials and retinal vascular caliber in type 2 diabetes. Invest Ophthalmol Vis Sci 2010; 51: 482-486.
10. Nguyen TT, Wong TY. Retinal vascular changes and diabetic retinopathy. Curr Diab Rep 2009; 9: 277-283.
11. Sasongko MB, Wong TY, Nguyen TT, Cheung CY, Shaw JE, Wang JJ. Retinal vascular tortuosity in persons with diabetes and diabetic retinopathy. Diabetologia 2011; 54: 2409-2016.
12. Cheung N, Donaghue KC, Lie G, Rogers SL, Wang JJ, Lim SW, Jenkins AJ etal. Quantitative assessment of early diabetic retinopathy using fractal analysis. Diabetes Care 2009; 32: 106-110.
13. Sun C, Wang JJ, Mackey DA, Wong TY. Retinal vascular caliber: systemic, environmental, and genetic associations. Surv Ophthalmol 2009; 54: 74-95.
14. Kifley A, Wang JJ, Cugati S, Wong TY, Mitchell P. Retinal vascular caliber, diabetes and retinopathy. Am J Ophthalmol 2007; 143: 1024-1026.
15. Klein R, Klein BE, Moss SE, Wong TY, Sharrett AR. Retinal vascular caliber in persons with type 2 diabetes: the Wisconsin Epidemiological Study of Diabetic Retinopathy: XX. Ophthalmology 2006; 113: 1488-1498.
16. Nguyen TT, Wang JJ, Sharrett AR, Islam FM, Klein R, Klein BE, Cotch MF etal. Relationship of retinal vascular caliber with diabetes and retinopathy: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 2008; 31: 544-549.
17. Bulpitt CJ, Dollery CT, Kohner EM. The marginal plasma zone in the retinal microcirculation. Cardiovasc Res 1970; 4: 207-212.
18. Hubbard LD, Brothers RJ, King WN, Clegg LX, Klein R, Cooper LS, Sharrett AR etal. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities study. Ophthalmology 1999; 106: 2269-2280.
19. Knudtson MD, Lee K, Hubbard L, Wong T, Klein R, Klein B. Revised formulas for summarizing retinal vessel diameters. Curr Eye Res 2003; 27: 143-149.
20. Cheung CY, Hsu W, Lee ML, Wang JJ, Mitchell P, Lau QP, Hamzah H etal. A new method to measure peripheral retinal vascular caliber over an extended area. Microcirculation. 2010; 17: 495-503.
21. Klein R, Klein BE, Moss SE, Wong TY, Hubbard L, Cruickshanks KJ, Palta M. The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol 2004; 122: 76-83.
22. Roy MS, Klein R, Janal MN. Retinal venular diameter as an early indicator of progression to proliferative diabetic retinopathy with and without high-risk characteristics in African Americans with type 1 diabetes mellitus. Arch Ophthalmol 2011; 129: 8-15.
23. Klein R, Klein BE, Moss SE, Wong TY. Retinal vessel caliber and microvascular and macrovascular disease in type 2 diabetes: XXI: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology 2007; 114: 1884-1892.
24. Rogers SL, Tikellis G, Cheung N, Tapp R, Shaw J, Zimmet PZ, Mitchell P etal. Retinal arteriolar caliber predicts incident retinopathy: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study. Diabetes Care 2008; 31: 761-763.
25. Wong TY. Retinal vessel diameter as a clinical predictor of diabetic retinopathy progression: time to take out the measuring tape. Arch Ophthalmol 2011; 129: 95-96.
26. Stefansson E, Landers MB 3rd, Wolbarsht ML. Oxygenation and vasodilatation in relation to diabetic and other proliferative retinopathies. Ophthalmic Surg 1983; 14: 209-226.
27. de Jong FJ, Vernooij MW, Ikram MK, Ikram MA, Hofman A, Krestin GP, van der Lugt A etal. Arteriolar oxygen saturation, cerebral blood flow, and retinal vessel diameters. The Rotterdam Study. Ophthalmology 2008; 115: 887-892.
28. Wong TY, Islam FM, Klein R, Klein BE, Cotch MF, Castro C, Sharrett AR etal. Retinal vascular caliber, cardiovascular risk factors and inflammation: the multi-ethnic study of atherosclerosis (MESA). Invest Ophthalmol Vis Sci 2006; 47: 2341-2350.
29. Klein R, Klein BE, Knudtson MD, Wong TY, Tsai MY. Are inflammatory factors related to retinal vessel caliber? The Beaver Dam Eye Study. Arch Ophthalmol 2006; 124: 87-94.
30. Nguyen TT, Wang JJ, Wong TY. Retinal vascular changes in pre-diabetes and prehypertension: new findings and their research and clinical implications. Diabetes Care 2007; 30: 2708-2715.
31. Mandecka A, Dawczynski J, Blum M, Müller N, Kloos C, Wolf G, Vilser W etal. Influence of flickering light on the retinal vessels in diabetic patients. Diabetes Care 2007; 30: 3048-3052.
32. Nguyen TT, Kawasaki R, Wang JJ, Kreis AJ, Shaw J, Vilser W, Wong TY. Flicker light-induced retinal vasodilation in diabetes and diabetic retinopathy. Diabetes Care 2009; 32: 2075-2080.
33. Nguyen TT, Kawasaki R, Kreis AJ, Wang JJ, Shaw J, Vilser W, Wong TY. Correlation of light-flicker-induced retinal vasodilation and retinal vascular caliber measurements in diabetes. Invest Ophthalmol Vis Sci 2009; 50: 5609-5613.
34. Kern TS, Barber AJ. Retinal ganglion cells in diabetes. J Physiol 2008; 586: 4401-4408.
35. Bloomgarden ZT. Diabetic retinopathy. Diabetes Care 2008; 31: 1080-1083.
36. Garhöfer G, Zawinka C, Resch H, Kothy P, Schmetterer L, Dorner GT. Reduced response of retinal vessel diameters to flicker stimulation in patients with diabetes. Br J Ophthalmol. 2004; 88: 887-891.
37. Wang Y, Bower BA, Izatt JA, Tan O, Huang D. In vivo total retinal blood flow measurement by Fourier domain Doppler optical coherence tomography. J Biomed Opt. 2007; 12: 041215.
38. Gilmore ED, Hudson C, Nrusimhadevara RK, Harvey PT, Mandelcorn M, Lam WC, Devenyi RG. Retinal arteriolar diameter, blood velocity and blood flow response to an isocapnic hyperoxic provocation in early sight-threatening diabetic retinopathy. Invest Ophthalmol Vis Sci 2007; 48: 1744-1750.
39. Liew G, Sharrett AR, Kronmal R, Klein R, Wong TY, Mitchell P, Kifley A etal. Measurement of retinal vascular caliber: issues and alternatives to using the arteriole to venule ratio. Invest Ophthalmol Vis Sci 2007; 48: 52-57.
40. Kristinsson JK, Gottfredsdóttir MS, Stefánsson E. Retinal vessel dilatation and elongation precedes diabetic macular oedema. Br J Ophthalmol 1997; 81: 274-278.
41. McGeechan K, Macaskill P, Irwig L, Liew G, Wong TY. Assessing new biomarkers and predictive models for use in clinical practice: a clinician's guide. Arch Intern Med 2008; 168: 2304-2310.
42. McGeechan K, Liew G, Macaskill P, Irwig L, Klein R, Klein BE, Wang JJ etal. Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis. Am J Epidemiol 2009; 170: 1323-1332.